Gene polymorphisms predictive for dual TKI therapy

Details for Australian Patent Application No. 2008205457 (hide)

Owner University of Southern California

Inventors Lenz, Heinz-Josef

Agent Pizzeys

Pub. Number AU-A-2008205457

PCT Pub. Number WO2008/088861

Priority 60/885,620 18.01.07 US

Filing date 17 January 2008

Wipo publication date 24 July 2008

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

3 September 2009 PCT application entered the National Phase

  PCT publication WO2008/088861 Priority application(s): WO2008/088861

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008205459-Stem cell gene targeting

2008205456-Polymorphisms in the EGFR pathway as markers for cancer treatment